D
Axsome Therapeutics, Inc. AXSM
$118.51 $1.371.17% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 39.54% 13.08% 24.06% -3.86% -18.13%
Total Depreciation and Amortization 12.69% 16.49% 19.14% 18.24% 18.00%
Total Amortization of Deferred Charges -50.55% 7.75% 55.95% 7.18% -29.48%
Total Other Non-Cash Items 15.17% 21.51% -47.14% 150.68% 5.65%
Change in Net Operating Assets -162.63% -49.10% 273.69% 156.09% 272.97%
Cash from Operations -7.68% 18.88% 13.70% 65.21% 45.60%
Capital Expenditure 75.00% -244.90% -328.57% 75.74% 60.90%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 75.00% -244.90% -328.57% 75.74% 60.90%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -103,397.85% -146.01% -- -- --
Issuance of Common Stock 146.01% 1,366.81% 1,434.24% -12.28% -92.22%
Repurchase of Common Stock 33.13% -167.99% -90.36% -33.24% -298.80%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -200.90% -40.43% -183.74% 49.29% 86.06%
Cash from Financing 140.24% 2,565.88% 712,300.00% -8.89% -94.16%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 113.34% 73.62% 60.53% 156.86% -108.28%